PET amyloid ligand [ 11 C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease

ISSN： 1460-2156

Source： Brain, Vol.131, Iss.7, 2008-07, pp. : 1845-1853

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

11 C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

By Jack Clifford R.

Brain, Vol. 131, Iss. 3, 2008-03 ,pp. : 665-680

Oxford University Press

Access to resources Recommend Favorite

Cerebral amyloid PET imaging in Alzheimer’s disease

By Jack Clifford Barrio Jorge Kepe Vladimir

Acta Neuropathologica, Vol. 126, Iss. 5, 2013-11 ,pp. : 643-657

Springer Publishing Company

Access to resources Recommend Favorite

Development of a PET/SPECT agent for amyloid imaging in Alzheimer’s disease

By Wang Yanming Klunk William Debnath Manik Huang Guo-Feng Holt Daniel Shao Li Mathis Chester

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 55-62

Humana Press, Inc

Access to resources Recommend Favorite

Extramotor involvement in ALS: PET studies with the GABA A ligand [ 11 C]flumazenil

By Lloyd C.M.

Brain, Vol. 123, Iss. 11, 2000-11 ,pp. : 2289-2296

Oxford University Press

Access to resources Recommend Favorite

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [ 11 C] raclopride PET study

By Steeves T. D. L.

Brain, Vol. 132, Iss. 5, 2009-05 ,pp. : 1376-1385

Oxford University Press

Access to resources Recommend Favorite